Bay Shore Trust - 21 Nov 2024 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
10%+ Owner
Signature
/s/ Brian McNulty, Trustee
Issuer symbol
TELO
Transactions as of
21 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 17:06:10 UTC
Previous filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELO Common Stock (right to buy) Gift -100,000 -4.1% 2,339,025 21 Nov 2024 Common Stock 100,000 $3.73 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Bona Fide Gift. No compensation was given to the donor for the gifting of securities.